T12928 |
SK33
|
1928724-23-5
|
99.55%
|
|
SK33 is a potent and tissue selective anti-androgen agent. SK33 reduces androgen receptor (AR) transcriptional activity.
|
T14116 |
ACP-105
|
899821-23-9
|
99.53%
|
|
ACP-105 is a novel and potent nonsteroidal selective androgen receptor modulator (SARM) with partial agonist activity relative to the natural androgen testostero...
|
T10896L |
CSRM617 hydrochloride
|
1353749-74-2
|
99.47%
|
|
CSRM617 hydrochloride is a selective small-molecule inhibitor of the transcription factor ONECUT2 ( OC2, a master regulator of androgen receptor) with a K d of 7...
|
T8709 |
Nandrolone phenylpropionate
|
62-90-8
|
99.46%
|
|
Nandrolone phenylpropionate (Nandrolone phenpropionate) is an androgen receptor agonist. It mainly used to treat women with breast cancer and osteoporosis
|
T1261 |
Medroxyprogesterone Acetate
|
71-58-9
|
99.45%
|
|
Medroxyprogesterone Acetate (Farlutin) is a synthetic progestin that is derived from 17-hydroxyprogesterone. It is a long-acting contraceptive that is effective ...
|
T3137 |
Boldenone Undecylenate
|
13103-34-9
|
99.39%
|
|
Boldenone Undecylenate (Parenabol) is a synthetic steroid.
|
T26539 |
AC-262536
|
870888-46-3
|
99.38%
|
|
AC-262536 is a selective androgen receptor (SAR) modulator. It has partial agonist activity with respect to testosterone and suppresses luteinizing hormone.
|
T29111 |
VPC-13566
|
218464-59-6
|
99.37%
|
|
VPC-13566 is a BF3-specific small molecule, which effectively inhibited the androgen receptor transcriptional activity and displaced the BAG1L peptide from the B...
|
T3618 |
GSK-2881078
|
1539314-06-1
|
99.33%
|
|
GSK-2881078 is a selective androgen receptor modulator (SARM) that is being evaluated for effects on muscle growth and strength in subjects with muscle wasting t...
|
T2895 |
Lupeol
|
545-47-1
|
99.31%
|
|
Lupeol (Monogynol B) is a novel androgen receptor inhibitor with anti-inflammatory and antioxidant activity.
|
T14008 |
2,2,5,7,8-Pentamethyl-6-Chromanol
|
950-99-2
|
99.3%
|
|
2,2,5,7,8-Pentamethyl-6-Chromanol (PMC) is the anti-oxidant moiety of vitamin E (α-tocopherol), which has potent androgen receptor (AR) signaling modulation and ...
|
TCS1372 |
Atraric acid
|
4707-47-5
|
99.27%
|
|
Atraric acid derivatives as a new chemical lead structure for novel therapeutic compounds as AR antagonists, that can be used for prophylaxis or treatment of pro...
|
T9246 |
JNJ-63576253
|
2110428-64-1
|
99.27%
|
|
JNJ-63576253 is a Clinical Stage Androgen Receptor Antagonist for F877L Mutant and Wild-Type Castration-Resistant Prostate Cancer (mCRPC).
|
T3357 |
Clascoterone
|
19608-29-8
|
99.26%
|
|
Clascoterone (CB-03-01) is a new topical and peripherally selective androgen antagonist.
|
T16090L |
MK-0773 FA
|
|
99.17%
|
|
MK-0773 FA (MK-0773 FA (606101-58-0 Free base)) is a selective androgen receptor modulator with an IC50 value of 6.6 nM for AR, which can be used for the prevent...
|
T8217 |
Enzalutamide carboxylic acid
|
1242137-15-0
|
99.17%
|
|
Enzalutamide carboxylic acid is an antagonist of androgen receptor (AR) .
|
T10359 |
AR antagonist 1
|
1818885-54-9
|
99.07%
|
|
AR antagonist 1 is a potent antagonist of the androgen receptor. It binds to E3 ligase ligands with weak binding affinities to VHL protein in the synthesis of PR...
|
T22263 |
Bavdegalutamide
|
2222112-77-6
|
99.04%
|
|
Bavdegalutamide (ARV-110) is a PROTAC degrader of androgen receptor (AR). Bavdegalutamide can be used in studies about prostate cancer. Bavdegalutamide shows ora...
|
T5100 |
DJ-V-159
|
2253744-53-3
|
99%
|
|
DJ-V-159 is a GPRC6A agonist, targeting the G protein-coupled receptor family C group 6 member A (GPRC6A).
|
T6829 |
EPI-001
|
227947-06-0
|
99%
|
|
EPI-001 is an androgen receptor N-terminal domain antagonist with IC50 of ~6 μM and a selective PPAR-gamma modulator.
|